17-Oct-2025
Tumor-on-a-chip offers insight into cancer-fighting cells in immunotherapy
University of PennsylvaniaPeer-Reviewed Publication
The “tumor-on-a-chip” recreates the body’s tumor environment in miniature, complete with blood vessels and immune cells, so researchers can “see” what helps or hinders engineered immune cells inside solid tumors.
Adding vildagliptin, a drug currently used to treat type 2 diabetes, to the chip, allows many more CAR T cells to break through the protective tumor microenvironment and attack the tumor.
These chips could help accelerate the development of more efficacious and safer immunotherapies for cancer patients while reducing the need for the use of other preclinical models.
- Journal
- Nature Biotechnology
- Funder
- Cancer Research Institute, NIH/National Institutes of Health, U.S. National Science Foundation, Ministry of Trade, Industry and Energy of the Republic of Korea, National Research Foundation of Korea, Paul Allen Foundation, Ludwig Cancer Research, University of Pennsylvania